drugset / Trial / NCT00005918

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

NCT00005918

Phase 3 Completed 730 enrolled Bristol-Myers Squibb
Double-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T). One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).

Timeline

Start
2000-06
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified
Background Efavirenz Other / unclassified
Background Lamivudine Other / unclassified